MedMen Enterprises Inc. MMEN MMNFF reported fourth-quarter revenue of $42 million on Monday, up by 104% year-over-year, and record full-year revenue of $130 million, up by 227% year-over-year.
The cannabis company posted a fourth-quarter net loss of $82.9 million.
The gross margin for retail operations in the quarter was 50%.
2019 Results
The company's full-year adjusted EBITDA loss amounted to $172 million, more than triple the 2018 figure.
MedMen's net loss was $277 million for 2019; $79.1 million, or 75 cents per share, was attributable to the company’s shareholders, MedMen said.
The net loss in 2018 was $113.9 million.
“Fiscal 2019 was a transformative year for MedMen, with over 2 million completed retail transactions to date and revenues increasing 227% year-over-year,” Adam Bierman, MedMen's co-founder and CEO, said in a statement.
“Our success was due, largely in part, to our loyal customer base. Throughout the year, we served over 1 million customers from all 50 states and more than 100 countries. In California, the largest cannabis market in the world, MedMen surpassed a record $110 million in annualized run-rate retail revenue.”
MedMen detailed business developments including the launch of its delivery service in California and Nevada, the start of its new loyalty program, MedMen Buds; its continued Florida expansion and the termination of its merger with PharmaCann.
MedMen shares were down 17.27% at $1.15 at the time of publication.
Related Links:
Exclusive: MedMen CEO Talks Pharmacann M&A Termination, CFO Change
MedMen Opens Three New Florida Retail Locations, Bringing National Footprint To 29 Stores
Photo courtesy of MedMen.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.